Home LiteratureArticle Details
PMID: 3925947 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Binding of an aldose reductase inhibitor to renal glomeruli.

Biochemical and biophysical research communications ·Vol. 129 ·No. 2 ·1985-06-14 ·Pages 530-5

Cohen MP, Klepser H

Abstract

The aldose reductase inhibitor Sorbinil affects several membrane-associated complexes including Na/K-ATPase activity, transport processes, and impulse propagation. These considerations, coupled with the drug's aromatic nature, suggested the possibility of direct interaction with cell membranes. In the present study, binding of [3H]-Sorbinil to isolated glomeruli was demonstrated. Binding is dose-dependent and saturable, and can be inhibited by increasing concentrations of unlabeled Sorbinil. These results may help explain the compound's diverse effects on membrane-associated processes.

MeSH Terms
Aldehyde Reductase/antagonists & inhibitors Animals Binding Sites Cell Membrane/drug effects,metabolism Imidazoles/metabolism,pharmacology Imidazolidines In Vitro Techniques Kidney Glomerulus/metabolism Kinetics Male Rats Sugar Alcohol Dehydrogenases/antagonists & inhibitors Sugar Alcohols/metabolism
Chemicals
Imidazoles Imidazolidines Sugar Alcohols Sugar Alcohol Dehydrogenases Aldehyde Reductase sorbinil
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Cohen M P
Klepser H
Article Info
Journal
Biochemical and biophysical research communications
Abbr.
Biochem Biophys Res Commun
ISSN
0006-291X
Published
1985-06-14
Pages
530-5
Language
English
Region
United States
NLM ID
0372516
Subset
IM
Grants
NIADDK NIH HHS · AM32447 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com